Marvel Will Release The Amazing Venom #1 Soon
The upcoming comic book will feature Fred Myers wielding the Passenger symbiote.
Updated on Sept. 25, 2026 in Comic Books

Marvel is set to release The Amazing Venom #1 on September 30, 2026. This 32-page comic book follows Fred Myers as he bonds with a symbiote known as Passenger.
Why it matters
The story explores the aftermath of the conflict between Hela and Knull on Earth. Fans of the Venom mythos will see how these cosmic events reshape the character's path.
The Amazing Venom #1 spans 32 pages in total length. Stefano Caselli provided the cover art for the debut issue.
The players
Marvel
Marvel is a global entertainment company widely recognized for its extensive catalog of comic books and superhero media franchises.
Jordan Morris
Jordan Morris is a professional writer who has contributed to various creative projects within the comic book industry.
Fred Myers
Fred Myers is a recurring character in the Marvel universe who plays the central role in this new title.
The details
The creative team for this project includes writer Jordan Morris supported by artists Luke Ross, Julius Ohta, and David Curiel. The plot picks up in the wake of the major battle between Hela and Knull.
Timeline
September 30, 2026: The Amazing Venom #1 release date.
Roadmap
This release follows the structural precedent of the conflict between Hela and Knull. It marks a shift as the publisher focuses on the lingering consequences of major cosmic events.
Readers can expect this issue to be available at local comic shops starting on its release date. Fans looking to follow the post-Knull storyline will need to secure a copy to keep up with the current narrative developments.
The takeaway
Collectors and fans of the symbiote sub-genre should monitor their local retailers for the September 30 drop. Understanding the background of the Hela and Knull confrontation will provide the best context for the events in this new series.
Further reading
For more on new titles, visit the Comic Books section.
Source note: This article includes information reported by AIPT.






